Literature DB >> 6819079

In vitro tumor cell killing by peritoneal macrophages from mitomycin C-treated rats.

T Ogura, H Shindo, O Shinzato, M Namba, T Masuno, T Inoue, S Kishimoto, Y Yamamura.   

Abstract

The local cellular response induced by intraperitoneal injection of mitomycin C was examined in terms of cell-mediated cytotoxicity for tumor cells. An in vitro cytolysis assay involving 125I-iododeoxyuridine-labeled tumor target cells revealed that treatment of normal ACI/N rats (200 g) with a single intraperitoneal injection of mitomycin C (50, 100, or 200 micrograms) induced tumoricidal macrophages in the peritoneal cavity. The tumoricidal activity was dependent on the dose of mitomycin C injected and it was detectable as early as 1 day after the intraperitoneal injection of mitomycin C. In addition to the increased tumoricidal activity, the functional activities of the peritoneal macrophages were found to be increased with respect both to uptake of 2-deoxy-D-glucose and to phagocytosis of latex beads. Additional experiments excluded the possibility that the tumor cell cytolysis was the result of direct cytotoxicity by mitomycin C that might have been incorporated in the peritoneal macrophages or of nutrient depletion in the medium during the cytolysis assay. Furthermore, endotoxin contamination of the mitomycin C, which might have produced the activated macrophages, was not detected. The mechanism by which mitomycin C injected intraperitoneally induced the tumoricidal macrophages locally remains uncertain; however, it is possible also in clinical situations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6819079     DOI: 10.1007/bf00205310

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  22 in total

1.  Antitumor activity of squalene-treated cell-wall skeleton of Nocardia rubra in mice.

Authors:  M Yamawaki; I Azuma; I Saiki; M Uemiya; O Aoki; K Ennyu; Y Yamamura
Journal:  Gan       Date:  1978-10

2.  Characterization of the effects of endotoxin on macrophage tumor cell killing.

Authors:  J B Weinberg; H A Chapman; J B Hibbs
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

3.  Quantitative comparison of in vitro and in vivo methods for the detection of endotoxin.

Authors:  J F Cooper; J Levin; H N Wagner
Journal:  J Lab Clin Med       Date:  1971-07

4.  Spontaneous cytotoxicity of human peripheral blood mononuclear cells toward red blood cell targets. II. Time-dependent loss of suppressor cell activity.

Authors:  A V Muchmore; J M Decker; R M Blaese
Journal:  J Immunol       Date:  1977-11       Impact factor: 5.422

5.  Tumoricidal activity of peritoneal exudate cells from rats treated with mitomycin C.

Authors:  T Ogura; H Shindo; M Namba; Y Yamamura
Journal:  Gan       Date:  1980-12

6.  Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.

Authors:  H Kirchner; A V Muchmore; T M Chused; H T Holden; R B Herberman
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

7.  Activation in vitro of mouse macrophages by syngeneic, allogeneic, or xenogeneic lymphocyte supernatants.

Authors:  I J Fidler
Journal:  J Natl Cancer Inst       Date:  1975-11       Impact factor: 13.506

8.  Association of macrophage activation with antitumor effect on rat syngeneic fibrosarcoma by Nocardia rubra cell wall skeleton.

Authors:  T Ogura; N Namba; F Hirao; Y Yamamura; I Azuma
Journal:  Cancer Res       Date:  1979-11       Impact factor: 12.701

9.  Effects of adriamycin on the activity of mouse natural killer cells.

Authors:  A Santoni; C Riccardi; V Sorci; R B Herberman
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

10.  Anti-tumour effect in vitro of lymphocytes and macrophages from mice treated with Corynebacterium parvum.

Authors:  A Ghaffar; R T Cullen; N Dunbar; M F Woodruff
Journal:  Br J Cancer       Date:  1974-03       Impact factor: 7.640

View more
  11 in total

1.  Induction of tumoricidal macrophages from bone marrow cells of normal mice or mice bearing a colony-stimulating-factor-producing tumor.

Authors:  S Hosoe; T Ogura; S Hayashi; K Komuta; T Ikeda; T Shirasaka; I Kawase; T Masuno; S Kishimoto
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Effect of Nocardia rubra cell wall skeleton on augmentation of cytotoxicity function in human pleural macrophages.

Authors:  M Sakatani; T Ogura; T Masuno; S Kishimoto; Y Yamamura
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

3.  The effect of recombinant interleukin 2 in combination with mitomycin C on advanced cancer.

Authors:  T Akiyoshi; S Arinaga; S Nanbara; N Karimine; H Inoue; K Takamuku; R Abe; D Watanabe; M Nagamatsu; H Matsuoka
Journal:  Jpn J Surg       Date:  1990-05

4.  Augmentation of the generation of lymphokine-activated killer cells after a single dose of mitomycin C in cancer patients.

Authors:  S Nanbara; S Arinaga; T Akiyoshi
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Augmentation of the generation of cell-mediated cytotoxicity in culture by mitomycin C.

Authors:  T Akiyoshi; S Arinaga; H Tsuji
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

6.  Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide.

Authors:  M Hosokawa; Y Sawamura; T Morikage; F Okada; Z Y Xu; K Morikawa; K Itoh; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

7.  Mechanism(s) of in vitro macrophage activation with Nocardia rubra cell wall skeleton: the effects on macrophage activating factor production by lymphocytes.

Authors:  T Masuno; S Hayashi; M Ito; T Ikeda; T Ogura; S Kishimoto; Y Yamamura
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

8.  Analysis of therapeutic effect in experimental chemoimmunotherapy for rat ascites tumor.

Authors:  T Ogura; O Shinzato; M Sakatani; H Shindo; M Namba; S Kishimoto; Y Yamamura
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

9.  Immunohistochemical analysis of lymphocyte subsets infiltrating gastric carcinoma after mitomycin C administration.

Authors:  H Inoue; M Adachi; N Karimine; S Arinaga; H Ueo; D Korenaga; T Akiyoshi
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

10.  Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice.

Authors:  H Shindo; T Ogura; T Masuno; S Hayashi; S Kishimoto
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.